Evaluation of selenium effect on thyroid functio

Phase 3

Recruiting

• Conditions: End Stage Renal Disease.; End stage renal disease; N18.6

• Registration Number: IRCT20200502047270N1
• Lead Sponsor: Zahedan University of Medical Sciences

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Results First Posted: 1900-01-01
• Last Update Posted: 13 July 2020

Recruitment & Eligibility

• Status: Recruiting
• Sex: All
• Target Recruitment: 34

Inclusion Criteria

Hemodialysis duration more than 6 months

Exclusion Criteria

Sensitivity to selenium
Selenium consumption over the past 3 months
Thyroid disease needs treatment

Study & Design

• Study Type: interventional
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
Changes in serum free T4. Timepoint: At the beginning of the intervention and 12 weeks after the start of the intervention. Method of measurement: Chemi Luminescence.;Changes in serum free T4. Timepoint: At the beginning of the intervention and 12 weeks after the start of the intervention. Method of measurement: Chemi Luminescence.;Changes in TSH level. Timepoint: At the beginning of the intervention and 12 weeks after the start of the intervention. Method of measurement: Chemi Luminescence.;Changes in rT3 level. Timepoint: At the beginning of the intervention and 12 weeks after the start of the intervention. Method of measurement: Chemi Luminescence.;Changes in Selenium level. Timepoint: At the beginning of the intervention and 12 weeks after the start of the intervention. Method of measurement: atomic absorption spectrophotometry.